| Serial Number | 98468761 |
| Word Mark | NT NOVOTECH BIOTECH'S PARTNER AT EVERY PHASE |
| Filing Date | Tuesday, March 26, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, March 18, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, March 18, 2025 |
| Description of Mark | The mark consists of the stylized letters NT positioned to the left of the word NOVOTECH. Beneath NOVOTECH are the words "Biotech's Partner at Every Phase". |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Business advisory and consultancy services relating to product development; business advisory and consultancy services relating to regulatory compliance; business research services; market research services; all of the aforementioned services being in the fields of pharmaceuticals, biotechnology and other related industries |
| Goods and Services | Scientific research in the nature of conducting clinical trials for others; conducting and managing clinical trials, including clinical trials for pharmaceuticals, biotechnology and other related industries; providing information about the results of clinical trials, including clinical trials for pharmaceuticals and biotechnology; scientific research; medical research, namely, scientific research for medical purposes; preparation of statistics for scientific research; preparation of biostatistics for scientific research in the fields of pharmaceuticals, biotechnology and other related industries; provision of information and data relating to medical and scientific research for pharmaceuticals, biotechnology and other related industries; database design and development services to process data collected from clinical trials; medical research services, namely medical monitoring services for research in the fields of pharmaceuticals, biotechnology and other related industries; quality audits, namely, quality control for others; preparation of reports and applications to regulators relating to aspects of clinical trials; provision and exchange of information and data exchange between scientists, manufacturers and health authorities relating to pharmaceutical and biotechnology quality standards; technical writing of clinical report forms which are required by clinical trial drug protocols |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 26, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | Thursday, March 14, 2024 |
| First Use In Commerce Date | Thursday, March 14, 2024 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 26, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, March 14, 2024 |
| First Use In Commerce Date | Thursday, March 14, 2024 |
| Party Name | NOVOTECH HOLDINGS USA LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Charleston, SC 29403 |
| Party Name | NOVOTECH HOLDINGS USA LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Charleston, SC 29403 |
| Event Date | Event Description |
| Tuesday, March 26, 2024 | NEW APPLICATION ENTERED |
| Thursday, July 11, 2024 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Wednesday, August 28, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, October 6, 2024 | ASSIGNED TO EXAMINER |
| Friday, December 6, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, December 6, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, December 6, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, December 18, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 18, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 18, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 18, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, December 26, 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, February 5, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 11, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 11, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, March 12, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 18, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 18, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |